Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Exam 2 Review Questions for Nursing Students, Quizzes of Pharmacology

A set of review questions for an exam focused on pharmacology and nursing care for various cardiovascular and neurological conditions. The questions cover topics such as adrenergic agonists, epinephrine, atenolol, bethanechol, pilocarpine, cholinesterase inhibitors, anticholinergic drugs, and carbidopa-levodopa. The questions are designed to test students' understanding of drug actions, therapeutic effects, and nursing interventions.

Typology: Quizzes

2023/2024

Uploaded on 02/24/2024

sarah-waters
sarah-waters 🇺🇸

3 documents

1 / 7

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
Exam 2 Review Questions
1. A patient with cardiac decompensation is receiving an adrenergic agonist
as a continuous infusion. The patient’s blood pressure has increased from
82/50 mmHg to 130/80 mmHg. What is the nurse’s next action? (USLO 1,
2, 3)
a. Assess the blood pressure readings twice a shift.
b. Assess the patient’s ECG and slow infusion.
c. Assess the patient’s respiratory rate and measure ABGs.
d. Assess the patient’s intake and output (I & O).
2. The nurse assesses a patient receiving epinephrine. Which finding will be
of greatest concern to the nurse? (USLO 1, 3)
a. Weak peripheral pulses and decreased heart rate.
b. Stronger peripheral pulses and increased heart rate.
c. Stable blood pressure and increased cardiac output.
d. Heart rate of 95 beats per minute and strong peripheral pulses.
3. The nurse is caring for a patient who has been recently diagnosed with
hypertension and is to receive an initial dose of atenolol. What is the
nurse’s primary intervention? (USLO 1, 2, 3, 4, 5)
a. Assess the patient’s heart rate for one full minute.
b. Teach the patient about the use of beta blockers.
pf3
pf4
pf5

Partial preview of the text

Download Exam 2 Review Questions for Nursing Students and more Quizzes Pharmacology in PDF only on Docsity!

1. A patient with cardiac decompensation is receiving an adrenergic agonist as a continuous infusion. The patient’s blood pressure has increased from 82/50 mmHg to 130/80 mmHg. What is the nurse’s next action? (USLO 1, 2, 3) a. Assess the blood pressure readings twice a shift. b. Assess the patient’s ECG and slow infusion. c. Assess the patient’s respiratory rate and measure ABGs. d. Assess the patient’s intake and output (I & O). 2. The nurse assesses a patient receiving epinephrine. Which finding will be of greatest concern to the nurse? (USLO 1, 3) a. Weak peripheral pulses and decreased heart rate. b. Stronger peripheral pulses and increased heart rate. c. Stable blood pressure and increased cardiac output. d. Heart rate of 95 beats per minute and strong peripheral pulses. 3. The nurse is caring for a patient who has been recently diagnosed with hypertension and is to receive an initial dose of atenolol. What is the nurse’s primary intervention? (USLO 1, 2, 3, 4, 5) a. Assess the patient’s heart rate for one full minute. b. Teach the patient about the use of beta blockers.

c. Call the health care provider to verify the order. d. Ask the patient if he has a history of any respiratory disease.

4. Which assessment assists the nurse in determining if bethanechol has had a therapeutic effect? (USLO 3) a. Neurologic assessment b. Muscular assessment c. Urinary assessment d. Gastric assessment 5. A 68-year-old client is diagnosed with open-angle glaucoma. The HCP prescribes pilocarpine eye drops. What action of this drug makes it a useful treatment for the client’s condition? (USLO 1, 3) a. The production of aqueous humor in the eyes is decreased. b. Ciliary muscles are paralyzed to decrease accommodation. c. Bilateral mydriasis with cycloplegia is accomplished. d. The outflow of aqueous humor in the eyes in increased. 6. A client prescribed a cholinesterase inhibitor for Alzheimer’s disease, and a family member asks the nurse how this medication works. Which explanation should the nurse use to describe this class of drug? (USLO 1, 2, 3, 4)

9. The nurse is caring for a patient taking an adrenergic blocker. Which statement made by the patient indicates an understanding of the teaching? (USLO 2, 4) a. “I will monitor my urine output.” b. “I will not eat protein at the same time I take my medication.” c. “I will need frequent lab draws.” d. “I will stand up slowly.” 10.A patient is taking benztropine. Which outcome assessment helps the nurse verify the therapeutic effect of this medication? (USLO 3) a. Patient is unable to talk. b. Patient has had a decrease in tremors. c. Patient can sit up unassisted. d. Patient has an increased heart rate. 11.The patient is scheduled to begin treatment with carbidopa-levodopa. A family member tells the nurse that the patient has a history of undergoing treatment for narrow-angle glaucoma. What is the highest priority action on the part of the nurse? (USLO 1, 2, 3, 4, 5) a. Contact the health care provider with this information. b. Reassure the family that this will not affect the patient’s treatment.

c. Contact the pharmacist since the dosage will need to be decreased. d. Contact the pharmacist since the dosage will need to be increased. 12.The patient has begun treatment with carbidopa-levodopa and complains to the nurse of brown urine. What does this symptom indicate to the nurse? (USLO 3) a. An anaphylactic reaction to the medication. b. An overdosage of the medication. c. An insufficient dosage of the medication. d. An expected side effect of the medication. 13.When administering rivastigmine, an acetylcholinesterase inhibitor to the patient with Alzheimer’s disease, what intervention is needed in the care plan? (USLO 3) a. Monitor the patient’s intellectual ability. b. Monitor the patient for tachycardia. c. Monitor the patient for weight loss. d. Monitor the patient’s ability to walk. 14.The nurse is teaching a patient diagnosed with myasthenia gravis about taking pyridostigmine. What statement requires follow up by the nurse? (USLO 1, 3, 4)

6. C

7. A

8. A

9. D

10.B

11.A

12.D

13.C

14.B